State of the art in platelet transfusion therapy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Transfusion Science

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0955-3886(96)00056-2PMID 10168555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Audit of Practice in Platelet Refractoriness

  1997cited by this paper
• Thrombopoietin: the primary regulator of platelet production.

  1995cited by this paper
• Modern Transfusion Medicine

  1995cited by this paper
• Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.

  1995cited by this paper
• Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients

  1995cited by this paper
• Collection and transfusion of blood and blood components in the United States, 1992

  1995cited by this paper
• The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.

  1995cited by this paper
• Occurrence of Allogeneic HLA and Non-HLA Antibodies After Transfusion of Prestorage Filtered Platelets and Red Blood Cells: A Prospective Study

  1995cited by this paper
• Leucocyte depletion of blood and blood components

  1994cited by this paper
• Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group

  1994cited by this paper
• Use of single donor platelets.

  1994cited by this paper
• Biologic effects of leukocytes present in transfused cellular blood products.

  1994cited by this paper
• Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.

  1994cited by this paper
• Passenger leukocytes, cytokines, and transfusion reactions.

  1994cited by this paper
• THE MANAGEMENT OF HAEMORRHAGE IN THE REFRACTORY NON‐ALLOIMMUNIZED THROMBOCYTOPENIC PATIENT

  1994cited by this paper
• Biologic effects of leukocytes present in transfused cellular blood products

  1994cited by this paper
• Relative Importance of Immune and Non‐Immune Causes of Platelet Refractoriness

  1994cited by this paper
• Collection and transfusion of blood and blood components in the United States, 1989

  1993cited by this paper
• Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL‐6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL‐6 levels and febrile transfusion reactions

  1993cited by this paper
• Platelet transfusions: the 20,000/microL trigger [see comments]

  1993cited by this paper
• Platelet transfusions: the 20,000/microL trigger.

  1993cited by this paper
• Is white cell reduction cost‐effective?

  1993cited by this paper
• New trends in the preparation and storage of platelets

  1992cited by this paper
• New trends in the preparation and storage of platelets.

  1992cited by this paper
• An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion.

  1992cited by this paper
• Platelet quality after 15‐day storage of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium

  1992cited by this paper
• Wolf in wolf's clothing: is it time to raise the bounty on the passenger leukocyte?

  1992cited by this paper
• Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

  1992cited by this paper
• Prophylactic platelet transfusion

  1992cited by this paper
• Current trends: evolving concepts in transfusion medicine. Leukoreduced blood components: "you can filter now or you can filter later.".

  1992cited by this paper
• Guidelines for platelet transfusions

  1992cited by this paper
• Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.

  1991cited by this paper
• Leukocyte Filtration Removes Infectious Particulate Debris but Not Free Virus Derived from Experimentally Lysed HIV‐infected Cells

  1991cited by this paper
• Prevention of alloimmunization against platelets.

  1991cited by this paper
• Theoretic and practical aspects of platelet crossmatching.

  1990cited by this paper
• Collection and transfusion of blood in the United States, 1982-1988.

  1990cited by this paper
• Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium

  1989cited by this paper
• Controversies in platelet transfusion therapy.

  1980cited by this paper
• Thrombocytopenia: mechanisms and management of defects in platelet production.

  1978cited by this paper
• Platelet transfusion therapy; the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing.

  1969cited by this paper
• Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes.

  1966cited by this paper
• Effect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy study

  1966cited by this paper
• Nonhemolytic Febrile Transfusion Reactions

  1966cited by this paper
• ABSORPTION AND METABOLISM OF ASPIRIN ADMINISTERED IN ENTERIC-COATED TABLETS.

  1965cited by this paper
• CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963.

  1965cited by this paper

• Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten

  2021cites this paper
• Genetic-algorithm-based artificial neural network modeling for platelet transfusion requirements on acute myeloblastic leukemia patients

  2011cites this paper
• Akuter Blutverlust in der operativen Medizin

  2010cites this paper
• 2 Platelet Concentrates

  2009cites this paper
• Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 × 109 and 20 × 109 per L

  2007cites this paper
• Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 × 109 or 20 × 109 per L

  2007cites this paper
• Coagulation disorders in liver disease.

  2002cites this paper
• Coagulation Disorders in Liver Disease

  2002cites this paper
• Acute Intravascular Hemolysis in Two Patients Transfused with Dry-Platelet Units Obtained from the Same ABO Incompatible Donor

  2000cites this paper
• Plateletapheresis with the New Baxter-Amicus Blood Cell Separator: An Italian Multicenter Study

  1998cites this paper
• Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.

  1998cites this paper